Active Ingredient History
Cromolyn is a mast cell stabilizer. In vitro and in vivo animal studies have shown that cromolyn sodium inhibits the degranulation of sensitized mast cells, which occurs after exposure to specific antigens. Cromolyn sodium acts by inhibiting the release of histamine and SRS-A (slow-reacting substance of anaphylaxis) from the mast cell. Cromolyn is indicated in the management of patients with mastocytosis, prophylaxis (long-term control) of bronchial asthma, prevention of exercise-induced bronchospasm, prevention and treatment of seasonal and perennial allergic rhinitis The most frequently reported adverse reactions attributed to cromolyn sodium treatment were: throat irritation or dryness, bad taste, cough, wheeze, nausea. NCATS
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Conjunctivitis, Allergic (approved 1994)
Mastocytosis (approved 1994)
Rhinitis, Allergic, Seasonal (approved 1994)
Alzheimer Disease (Phase 3)
Amyotrophic Lateral Sclerosis (Phase 2)
Asthma ()
Asthma, Exercise-Induced (Phase 2)
Cognition Disorders (Phase 2)
Cough (Phase 2)
COVID-19 (Phase 3)
Dyspepsia (Phase 4)
Eosinophilic Esophagitis (Phase 4)
Exercise (Phase 3)
Gastroesophageal Reflux (Phase 1)
Healthy Volunteers (Phase 1/Phase 2)
Idiopathic Pulmonary Fibrosis (Phase 2)
Ischemic Stroke (Phase 2)
Kidney Failure, Chronic (Phase 2)
Lung Diseases (Phase 1)
Lung Transplantation (Phase 1)
Mastocytosis (Phase 2)
Mastocytosis, Cutaneous (Phase 2)
Mastocytosis, Systemic (Phase 2)
Pneumonia, Viral (Phase 3)
Prostatitis (Early Phase 1)
Pruritus (Phase 2)
Psoriasis (Phase 2)
Respiratory Aspiration (Phase 1)
Rosacea (Phase 1/Phase 2)
Schizophrenia (Phase 1/Phase 2)
Stroke (Phase 3)
Triple Negative Breast Neoplasms (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue